Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OGN | Common Stock | Options Exercise | $0 | +7.75K | +24.45% | $0.00 | 39.5K | Mar 31, 2023 | Direct | |
transaction | OGN | Common Stock | Tax liability | -$61.3K | -2.66K | -6.73% | $23.09 | 36.8K | Mar 31, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OGN | Restricted Stock Units | Options Exercise | $0 | -7.75K | -33.33% | $0.00 | 15.5K | Mar 31, 2023 | Common Stock | 7.75K | Direct | F1, F2 | |
transaction | OGN | Restricted Stock Units | Award | $0 | +36.1K | $0.00 | 36.1K | Mar 31, 2023 | Common Stock | 36.1K | Direct | F3, F4 | ||
transaction | OGN | Stock Option (right to buy) | Award | $0 | +130K | $0.00 | 130K | Mar 31, 2023 | Common Stock | 130K | $23.52 | Direct | F5 |
Id | Content |
---|---|
F1 | Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock. |
F2 | On March 31, 2023, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2024 and March 31, 2025. |
F3 | The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon common stock for each RSU. |
F4 | These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 31, 2024, March 31, 2025 and March 31, 2026. |
F5 | The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2024, March 31, 2025 and March 31, 2026. |